Revanesse

Canadian-based Prollenium Medical Technologies produces cutting-edge products. Revanesse® dermal fillers containing cross-linked hyaluronic acid are characterised by their high safety and long-term effect. Revanesse® injectable fillers are of non-animal origin, have a high viscosity and therefore form a thicker gel. The Revanesse® brand offers products that fill deep wrinkles, lines and skin defects, as well as products designed for volumetric modelling of the face, for example the cheeks. The long-term effect is visible for up to 18 months after application.